Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder
NCT02468830
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
58
Enrollment
OTHER
Sponsor class
Conditions
Overactive Bladder
Urinary Incontinence
Interventions
DRUG:
mirabegron
Sponsor
CHU de Quebec-Universite Laval